Participants
illness, cognitive impairment, overweight or obese [
Inclusion and exclusion, dementia, sarcopenic obesity, Sarcopenia, weight loss, hearing and vision
AUTOIMMUNE DISEASE, SARCOPENIA, HEART DISEASE, METABOLIC DISORDERS
Participants were recruited from June 2020 to November 2020 by convenience sampling. The study was promoted by displaying the posters in three largest community health centres which provided a free annual physical health examination to all citizens from the age of 60 in Nanjing, China, and community staffs also helped introduce the research project to older people who came to receive the free physical health check. Initially, participants were identified to be overweight or obese [
Inclusion and exclusion criteria of the participants(a) community-dwelling older people aged 60 years old or above;(b) who met the diagnostic criteria of sarcopenic obesity according to the Asian Sarcopenia Working Group [i) ii) (c) who were able to communicate, read, and write without significant hearing and vision problems.(a) those with any form of illness or condition that may influence food intake and digestion (such as severe heart disease, metabolic disorders, autoimmune disease, cancer);(b) having cognitive impairment (e.g., dementia), which may impede delivery of the intervention;(c) already adhering to special dietary restrictions, including a diabetes-specific diet, a vegetarian diet, or a ketogenic diet;(d) taking medications that may influence eating behaviour, digestion, or metabolism (such as weight loss medication);(e) being addicted to alcohol, which affects efforts to change dietary behaviour;(f) having any metal device implanted in their body, such as a pacemaker because low-level currents will flow through the body when doing the bioelectric impedance analysis, which may cause the device to malfunction.